{"id":15110,"date":"2019-11-06T11:56:43","date_gmt":"2019-11-06T10:56:43","guid":{"rendered":"http:\/\/miunidad.eu\/porib.com\/?p=15110"},"modified":"2023-03-01T13:46:28","modified_gmt":"2023-03-01T12:46:28","slug":"de-andres-nogales-f-gay-pobes-pr-ines-m-polanco-sanchez-c-alves-d-oyaguez-i","status":"publish","type":"post","link":"https:\/\/porib.com\/en\/de-andres-nogales-f-gay-pobes-pr-ines-m-polanco-sanchez-c-alves-d-oyaguez-i\/","title":{"rendered":"de Andr\u00e9s-Nogales F, Gay-Pobes PR, In\u00eas M, Polanco S\u00e1nchez C, Alves D, Oyag\u00fcez I"},"content":{"rendered":"<div class=\"col80\">\n<p class=\"miniatura_foto\" style=\"text-align: justify;\"><strong><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-14157 alignleft\" src=\"https:\/\/porib.com\/wp-content\/uploads\/2021\/09\/ISPOR.jpg\" alt=\"\" width=\"120\" height=\"120\" \/><\/strong><\/p>\n<p style=\"text-align: justify;\"><strong style=\"text-align: justify;\">de Andr\u00e9s-Nogales F, Gay-Pobes PR, In\u00eas M, Polanco S\u00e1nchez C, Alves D, Oyag\u00fcez I<\/strong><\/p>\n<p>&nbsp;<\/p>\n<\/div>\n<div class=\"col80\">\n<p>&nbsp;<\/p>\n<div class=\"col80p\">\n<h6><\/h6>\n<h6 style=\"text-align: justify;\">Cost-effectiveness analysis of apixaban versus edoxaban for stroke prevention in non-valvular atrial fibrilation Portuguese patients<\/h6>\n<h6 style=\"text-align: justify;\"><strong>22nd<\/strong><strong> Annual European Congress International Society for Pharmacoeconomics &amp; Outcomes Research (ISPOR). Copenhague (Dinamarca). 2-6 nov 2019<\/strong><\/h6>\n<p><a href=\"https:\/\/porib.com\/wp-content\/uploads\/2019\/11\/264.pdf\" target=\"_blank\" rel=\"noopener\">POSTER<\/a><\/p>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>de Andr\u00e9s-Nogales F, Gay-Pobes PR, In\u00eas M, Polanco S\u00e1nchez C, Alves D, Oyag\u00fcez I &nbsp; &nbsp; Cost-effectiveness analysis of apixaban versus edoxaban for stroke prevention in non-valvular atrial fibrilation Portuguese patients 22nd Annual European Congress International Society for Pharmacoeconomics &amp; Outcomes Research (ISPOR). Copenhague (Dinamarca). 2-6 nov 2019 POSTER<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"quote","meta":{"footnotes":""},"categories":[116,915,246],"tags":[],"class_list":["post-15110","post","type-post","status-publish","format-quote","hentry","category-ace-acu-tipo-de-proyecto","category-cardiovascular","category-international-society-of-pharmacoeconomics-and-outcomes-research","post_format-post-format-quote"],"translation":{"provider":"WPGlobus","version":"2.10.3","language":"en","enabled_languages":["es","en"],"languages":{"es":{"title":true,"content":true,"excerpt":false},"en":{"title":false,"content":false,"excerpt":false}}},"_links":{"self":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/15110"}],"collection":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/comments?post=15110"}],"version-history":[{"count":7,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/15110\/revisions"}],"predecessor-version":[{"id":23171,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/15110\/revisions\/23171"}],"wp:attachment":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/media?parent=15110"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/categories?post=15110"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/tags?post=15110"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}